熱門資訊> 正文
mmuCell任命Olivier te Boekhorst为新任首席执行官
2025-11-05 05:28
- ImmuCell (NASDAQ:ICCC) announced on Tuesday that Olivier te Boekhorst will serve as President and CEO of the company effective November 1, 2025.
- The company’s Board of directors appointed te Boekhorst to the Board of directors along with Timothy C. Fiori as CFO.
- Olivier te Boekhorst will be succeeding Michael F. Brigham, but he will continue as a member of the Board and serve as a special advisor to the CEO until January of 2026.
More on ImmuCell
- ImmuCell Corporation: At A Major Inflection Point
- ImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript
- ImmuCell announces preliminary sales results for Q3
- ImmuCell outlines cautious H2 outlook as capacity expansion supports First Defense suite
- Seeking Alpha’s Quant Rating on ImmuCell
推薦文章
四大利空擾動，恆生科指跌入技術性熊市！港股何時展開反彈？
華盛早報 | 1月再降息？瑞銀稱市場低估其概率；特斯拉大漲超3%創年內新高
華盛早報 | 美聯儲主席人選生變？除了哈塞特，特朗普也支持沃什；AI泡沫論重燃」？甲骨文大跌后緊急迴應
新股申購 | 諾比侃、翰思艾泰-B、輕松健康三隻新股今起招股！
新興市場套利狂潮未止！華爾街看好2026年高收益貨幣前景
詳解美聯儲意外「擴表」，影響幾何？
港股周報 | 定調2026！中央經濟工作會議機構最新解讀來了；中興通訊遭遇重磅利空后，擬至多回購12億元股份
一周財經日曆 | 聚焦數據！11月非農就業報告和CPI年率接踵而來；傳日本央行下周加息「板上釘釘」；美光財報出爐
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
